{
    "title": "AstraZeneca's Farxiga cuts death risk in heart failure patients -study",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11152349/AstraZenecas-Farxiga-cuts-death-risk-heart-failure-patients-study.html",
    "date": "2022-08-27",
    "keywords": [
        "heart",
        "failure",
        "ejection",
        "fraction",
        "death",
        "drug",
        "risk",
        "analysis",
        "farxiga",
        "benefit",
        "study",
        "jardiance",
        "grover",
        "hospitalisation",
        "cardiology",
        "blood",
        "year",
        "trial",
        "jhund",
        "professor",
        "therapy",
        "blockbuster",
        "door",
        "increase",
        "class",
        "kidney",
        "disease",
        "medication",
        "mortality",
        "company",
        "form",
        "society",
        "congress",
        "ability",
        "body",
        "studys",
        "goal",
        "reduction",
        "use",
        "data",
        "farxigas",
        "population",
        "dobber",
        "business",
        "eli",
        "co",
        "boehringer",
        "deliver",
        "cause",
        "close",
        "muscle",
        "range",
        "health",
        "half",
        "remainder",
        "irrespective",
        "university",
        "glasgow",
        "prognosis",
        "need",
        "spectrum",
        "ef",
        "quarter",
        "forefront",
        "coauthor",
        "scott",
        "solomon",
        "medicine",
        "school",
        "brigham",
        "hospital",
        "availability",
        "cost",
        "reporting",
        "editing",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}